AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

METTL3 promotes esophageal squamous cell carcinoma progression and reduces chemosensitivity to paclitaxel through the CASP9/BIRC3-dependent apoptosis pathway

Pengxiang Jia,c,1Bo Wana,b,1( )Minghui GaoaShaohua YinaHan WuaJunjie WangaYuting MadWeihua Xue,f( )Minghua Wanga,f( )
Department of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China
School of Life Sciences, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China
Suzhou Ruihua Orthopedic Hospital, Suzhou, Jiangsu 215104, China
CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, China
Department of Thoracic and Cardiac Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China
State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China

1 These authors contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Ji P, Wan B, Gao M, et al. METTL3 promotes esophageal squamous cell carcinoma progression and reduces chemosensitivity to paclitaxel through the CASP9/BIRC3-dependent apoptosis pathway. Genes & Diseases, 2026, 13(1). https://doi.org/10.1016/j.gendis.2025.101693

137

Views

1

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Received: 07 July 2024
Published: 27 May 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).